Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...

What’s the best way to rank countries based on medal count? By The Learning Network A new collection of graphs, maps and charts organized by topic and type from our “What’s Going On in This ...

The FDA approved ribociclib (Kisqali) for adjuvant treatment of high-risk, hormone receptor-positive, HER2-negative early breast cancer. The FDA approved ribociclib (Kisqali) with an aromatase ...

PC hardware is nice, but it’s not much use without innovative software. I’ve been reviewing software for PCMag since 2008, and I still get a kick out of seeing what's new in video and photo ...

Chrome OS is an open-sourced Linux-based operating system designed by Google. The operating system comes preinstalled on some select devices. It is fast, stable, and secure. Most of us don’t ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The FDA on Tuesday approved ribociclib (Kisqali) in combination with endocrine therapy as adjuvant treatment for early ...

The team found adding ribociclib, a drug that belongs to a class of CDK4/6 inhibitors, to standard hormone therapy not only ...

Never mind though, because [Michael MJD] has a video showing how an RT can be given a new life from an unlikely source, with the installation of Raspberry Pi OS. The video pretty closely follows ...

In this article, we will demonstrate how to use the graphing feature in the Windows calculator to try and make mathematics more fun. Microsoft has always thrived to kick up a notch the Windows ...

The US Food and Drug Administration (FDA) approved ribociclib (Kisqali, Novartis) in combination with an aromatase inhibitor for adult patients with hormone receptor (HR)-positive, human epidermal ...

Basel, September 17, 2024 – Novartis today announced that the US Food and Drug Administration (FDA) has approved Kisqali ® (ribociclib) in combination with an aromatase inhibitor (AI ...

Next-generation graph database developer Neo4j has raised $325 million in a Series F round of financing that the company described as the largest investment in a private database company.